Get started
VIKING THERAPEUTICS INCVIKING THERAPEUTICS INCVIKING THERAPEUTICS INC

VIKING THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

1VKTX chart


Full chart

1VKTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.97 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.065 EUR
Net income (FY)
‪−106.22 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪108.96 M‬
Beta (1Y)
1.31

Employees


Employees (FY)
36
Change (1Y)
+9 +33.33%
Revenue / Employee (1Y)
0.00 EUR
Net income / Employee (1Y)
‪−2.95 M‬ EUR

About Viking Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Brian Lian
Website
vikingtherapeutics.com
Headquarters
San Diego
Founded
2012
FIGI
BBG01TNXKZW2
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Check out other big names from the same industry as 1VKTX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1VKTX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 1VKTX is 27.885 EUR — it has decreased by −0.41% in the past 24 hours. Watch VIKING THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange VIKING THERAPEUTICS INC stocks are traded under the ticker 1VKTX.
1VKTX stock has risen by 2.63% compared to the previous week, the month change is a 17.32% rise, over the last year VIKING THERAPEUTICS INC has showed a 23.00% increase.
We've gathered analysts' opinions on VIKING THERAPEUTICS INC future price: according to them, 1VKTX price has a max estimate of 106.64 EUR and a min estimate of 25.59 EUR. Watch 1VKTX chart and read a more detailed VIKING THERAPEUTICS INC stock forecast: see what analysts think of VIKING THERAPEUTICS INC and suggest that you do with its stocks.
1VKTX reached its all-time high on Jul 10, 2025 with the price of 26.440 EUR, and its all-time low was 21.200 EUR and was reached on Jun 23, 2025. View more price dynamics on 1VKTX chart.
See other stocks reaching their highest and lowest prices.
1VKTX stock is 5.59% volatile and has beta coefficient of 1.31. Track VIKING THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is VIKING THERAPEUTICS INC there?
Today VIKING THERAPEUTICS INC has the market capitalization of ‪3.05 B‬, it has increased by 1.68% over the last week.
Yes, you can track VIKING THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
VIKING THERAPEUTICS INC is going to release the next earnings report on Jul 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1VKTX earnings for the last quarter are −0.38 EUR per share, whereas the estimation was −0.30 EUR resulting in a −25.00% surprise. The estimated earnings for the next quarter are −0.38 EUR per share. See more details about VIKING THERAPEUTICS INC earnings.
VIKING THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1VKTX net income for the last quarter is ‪−42.18 M‬ EUR, while the quarter before that showed ‪−34.21 M‬ EUR of net income which accounts for −23.28% change. Track more VIKING THERAPEUTICS INC financial stats to get the full picture.
No, 1VKTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 17, 2025, the company has 36 employees. See our rating of the largest employees — is VIKING THERAPEUTICS INC on this list?
Like other stocks, 1VKTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.